1Kawashimal I, Takigucki Y. Interleukin-11: a novel stroma-derived cytokine[J]. Prog Growth Factor Res, 1992,4(3):191.
2Bruno E,Briddell RA,Cooper RJ, et al. Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocyte progenitor cells[J]. Exp Hematol, 1991,19(5):378.
3Byrstein SA, Mei RL, Henthorn J, et al. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakarycoytes in vitro[J]. J Cell Physiol, 1992,153(2):305.
4Teramura M,Kobayashi S, Hoshino S, et al. Interleukin-11 enhances human megakaryocytopoiesis in vitro[J].Blood, 1992,79(2):327.
5Neben TY, Loebelenz J, Hayes L, et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases periphral[J]. Blood, 1993,81 (4): 901.
6Musashi M,Clark SC,Sudo T, et al. Synergistic interactions between interleukin-ll and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice[J]. Blood, 1991,78(6):1448.
7Quesniaux VF, Clark SC, Turner K, et al. Interleukin-11 stimulate multiple phases of erythropoiesis in vitro[J].Blood,1992,80(5):1218.
8Hawley RG, Fong AZ, Ngan BY, et al. Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukia 11 bone marrow chimeras[J]. J Exp Meo,1993,178(4):1175.
9Reynold CH. Clinical efficacy of rhIL-11[J]. Oncology,2000,14(9 Supply8) :32.
10Isaacs C,Robert NJ,Bailey FA, et aL Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin[J]. J Clin Oncol, 1997, 15(11):3368.
同被引文献22
1Teamura M, Kobayashi S, Hoshino S, et al. Interleukin-llenhances human megakaryocytopoiesis in vitro[J]. Blood, 1992, 79(2): 327-331.
2Auernhammer C J, Melmed S. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis[J]. Endocrinology, 1999, 140(4):1559-1566.
3Taniguchi K, Karin M. 1176 and related cytokines as the critical lynchpins between inflammation and cancer[J]. Semin Immunol, 2014,26 (1): 54-74.
4Guk KD, Kuprash DV. Interleukin-11, an IL-6 like cyto- kine[J]. Mol Biol(Mosk) ,2011,45(1) :44-55.
5Necula LG, Chivu-Economescu M, Stanciulescu EL, et al. IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mu- tations in Gp130 subunits[J]. J Gastrointestin Liver Dis, 2012,21(1) :23-29.
6Li TM,Wu CM, Huang HC, et al. Interleukin-ll increa- ses cell motility and up-regulates intercellular adhesion molecule-1 expression in human chondrosarcoma cells[J].J Cell Biochem,2012,113(11) :3353-3362.
7Gao YB,Xiang ZL,Zhou LY, et al. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to hone[J].J Cancer Res Clin On- col, 2013,139(4) : 669-679.
8Pan D,Xu L,Liu H,et al. High expression of interleukin- 11 is an Independent indicator of poor prognosis in clear- cell renal cell carcinoma[J]. Cancer Sci, 2015,106 (5) : 592-597.
9Lay V, Yap J, Sonderegger S, et al. Interleukin I1 regu- lates endometrial cancer cell adhesion and migration via STAT3[J]. Int J Oncol, 2012,41 (2) : 759-764.
10Ren C,Chen Y, Han C, et al. Plasma interleukin-ll (IL- 11) levels have diagnostic and prognostic roles in patients with pancreatic cancer[J]. Tumour Biol, 2014,35 (11) : 11467-11472.
